Introduction {#Sec1}
============

As a potent hepatotoxin, carbon tetrachloride (CCl~4~) continues to serve as an important substance in medicinal research, particularly in the investigation of hepatotoxin-induced liver diseases \[[@CR1]\]. CCl~4~ activates the 2E1 isoform of cytochrome P450 (CYP2E1) and then forms highly reactive species CCl~3~\* and CCl~3~OO\* which initiates lipid peroxidation. Those reactive oxygen species (ROS) cause oxidative stress in the liver and attack several cellular targets, including endoplasmic reticulum, mitochondrial, and plasma membranes, which contribute to further cell damage. At the molecular level, CCl~4~ induces the expression of pro-inflammatory cytokines of tumor necrosis factor alpha (TNF-α) and interleukin-1 beta (IL-1β), which mediate the processes of apoptosis, inflammation, and fibrosis. On the other hand, treatment of CCl~4~ also activates transforming growth factors (TGF-α and TGF-β) which leads to the development of liver fibrosis \[[@CR2]\].

Daily consumption of garlic and garlic-related products in several countries, including the United States, decreased the risk of colon and stomach cancer \[[@CR3]\]. Previous research also revealed that S-allylmercaptocysteine (SAMC), the naturally occurring water-soluble derivative of garlic, possesses anti-tumor properties in several cancers. In colon cancer cells, SAMC is shown to inhibit cell growth, arrest cell cycle, and induces apoptosis via depolymerizing microtubule, activate JNK1 and caspase-3 \[[@CR4]\], as well as inactivating transcription factor NF-κB \[[@CR5]\]. In addition, in human gastric cancer cells, the anti-proliferative and pro-apoptosis effects of SAMC are associated with induction of caspase-3, caspase-9, p53, and Bax, rather than Bcl-2 and p21 \[[@CR6]\]. In vivo study of androgen-independent prostate cancer model points out that SAMC suppresses metastasis via up-regulating cell adhesion molecules E-cadherin \[[@CR7]\]. In rat cells and animal model, SAMC is also shown to play antioxidative effects in vitro and attenuates oxidative and nitrosative stresses in vivo \[[@CR8]\]. In an acetaminophen-induced liver injury model, SAMC exerts its protective effects against hepatotoxicity by the inhibition of CYP2E1 enzymatic activity, leading to the suppression of acetaminophen arylation of hepatic proteins \[[@CR9]\].

Although some efforts have been made to investigate the protection of SAMC in CCl~4~-induced liver damage \[[@CR10]\], there is a lack of information on the molecular mechanisms of SAMC on such protection, especially on the attenuation of hepatic oxidative stress and inflammation. In the present study, we investigated the detailed molecular mechanisms of the protective role of SAMC in CCl~4~-induced acute hepatotoxicity, which may shed some light on the prevention of liver damage by taking SAMC as a supplement in the daily diet.

Materials and methods {#Sec2}
=====================

Reagents {#Sec3}
--------

SAMC pure powder was a generous gift from Dr. Patrick M. T. Ling. It was dissolved in solvent buffer (10% L-dextrose and 1% gum Arabic (w/v) in phosphate-buffered saline, pH 4.5). Carbon tetrachloride was purchased from Tianjin Baishi Chemical (Tianjin, China). Murine anti-nitrotyrosine monoclonal antibody was purchased from Zymed (San Francisco, CA). Rabbit anti-CYP2E1 and anti-IκBα polyclonal antibodies were purchased from Millipore (Billerica, MA) and Cell Signaling (Danvers, MA), respectively.

Animals and treatment {#Sec4}
---------------------

Eight- to ten-week healthy male and female C57BL/b6N mice were purchased from the Laboratory Animal Unit (LAU), The University of Hong Kong. Mice were kept under standard conditions 1 week before CCl~4~ treatment with free access to animal chow and tap water. The animals were divided into four groups (*n* = 8--10 in each group): (1) control with vehicle administration (PBS or olive oil); (2) CCl~4~ single-dose treatment (50 μl/kg in olive oil; intraperitoneal injection); (3) SAMC single-dose treatment (200 mg/kg in PBS; intraperitoneal injection); and (4) CCl~4~ and SAMC co-treatment. The optimum dosage of SAMC used was previously shown to be effective in protecting from oxidative stress in mice \[[@CR11]\]. SAMC pre-treatment was performed 2 h before the CCl~4~ injection. After 8 h of CCl~4~ treatment, the mice were killed by an overdose of anesthesia according to the protocols approved by the Committee of Animal Use for Research and Teaching at The University of Hong Kong. The Laboratory Animal Unit of the University of Hong Kong is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC international). Blood and liver samples were collected for further analysis.

Tissue and blood samples processing and histopathological analysis {#Sec5}
------------------------------------------------------------------

Serum were collected by centrifugation of whole blood sample at 1,000×*g* for 10 min at 4 °C and stored at −80 °C. Liver tissue samples were fixed in 10% phosphate-buffered formalin, processed for histology, and embedded in paraffin. Five-micrometer tissue sections were stained with hematoxylin and eosin for histological analysis under LEICA Qwin Image Analyser (Leica Microsystems Ltd., Milton Keynes, UK).

Serum alanine aminotransferase assay {#Sec6}
------------------------------------

The level of hepatic injury can be detected by the increased level of alanine aminotransferase (ALT) in the serum. The ALT assay was performed by procedures described previously \[[@CR12]\].

RNA extraction and quantitative reverse-transcription polymerase chain reaction (real-time PCR) {#Sec7}
-----------------------------------------------------------------------------------------------

Total RNA was extracted from the liver samples using illustra™ RNAspin mini kit (GE healthcare, UK). The preparation of the first-strand cDNA was conducted following the instruction of the SuperScript™ First-Strand Synthesis System (Invitrogen, Calsbad, CA).

The mRNA expression levels of tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), glutathione peroxidase (GPx), catalase (CAT), Cu/Zn SOD, monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-2 (MIP-2), KC (murine IL-8 ortholog), interleukin-6 (IL-6), and transforming growth factor beta1 (TGF-β~1~) were measured by real-time PCR. The primers used in those real-time PCR reactions are listed in Table [1](#Tab1){ref-type="table"}. The annealing temperature of each reaction has been adjusted to 58 °C. Parallel amplification of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the internal control. Relative quantification was performed using the 2^−ΔΔCt^ method. The relative expression of the specific gene to the internal control was obtained and then expressed as percentage of the control expression in the Figures.Table 1Primer sequences for quantitative PCRTarget geneDirectionSequenceTNF-αForward5′-ATGAGCACAGAAAGCATGATC-3′Reverse5′-TACAGGCTTGTCACTCGAATT-3′IL-1βForward5′-CAGGCAGGCAGTATCACTCA-3′Reverse5′-AGGCCACAGGTATTTTGTCG-3′iNOSForward5′-GTGGTGACAAGCACATTTGG-3′Reverse5′-GGCTGGACTTTTCACTCTGC-3′COX-2Forward5′-GGAGAGACTATCAAGATAGTGATC3′Reverse5′-ATGGTCAGTAGACTTTTACAGCTC-3′GPxForward5′-TCCACCGTGTATGCCTTCTCC-3′Reverse5′-CCTGCTGTATCTGCGCACTGGA-3′CATForward5′-GAGGCAGTGTACTGCAAGTTCC-3′Reverse5′-GGGACAGTTCACAGGTATCTGC-3′Cu/Zn SODForward5′-CGAGCAGAAGGCAAGC-3′Reverse5′-GCCCAGGTCTCCAACA-3′MCP-1Forward5′-ACCAGCCAACTCTCACTGAAGC-3′Reverse5′-CAGAATTGCTTGAGGTGGTTGTG-3′MIP-2Forward5′-AGTGAACTGCGCTCTCAATG-3′Reverse5′-CTTTGGTTCTTCCGTTGAGG-3′KCForward5′-CTGTCAGTGCCTGCAGACCA-3′Reverse5′-CCAAGGGAGCTTCAGGGTCA-3′IL-6Forward5′-CCGGAGAGGAGACTTCACAG-3′Reverse5′-GGAAATTGGGGTAGGAAGGA-3′TGF-β~1~Forward5′-CTTCAGCTCCACAGAGAAGAACTGC-3′Reverse5′-CACGATCATGTTGGACAACTGCTCC-3′GAPDHForward5′-CCTTCATTGACCTCAACTACATGGT-3′Reverse5′-TCATTGTCATACCAGGAAATGAGCT-3′

Determination of malondialdehyde level {#Sec8}
--------------------------------------

The malondialdehyde (MDA) levels of liver samples were determined using a Bioxytech LPO-586™ kit (Oxis Research, Portland, OR). The reaction product was measured spectrophotometrically at 586 nm. Standard curves were constructed using 1,1,3,3-tetraethoxypropane as a standard. The MDA levels were normalized with corresponding protein amounts determined by Bio-Rad Protein Assay Kit (Bio-Rad, Hercules, CA) and represented as percentage against control level.

Western blotting {#Sec9}
----------------

Protocols for cytosolic and nuclear protein extraction were previously described \[[@CR12]\]. Protein was diluted and mixed with 2× sample buffer (0.1 M Tris--HCl, pH 6.8, 20% glycerol, 4% sodium dodecyl sulfate, 0.2% bromophenol blue, and 5.25% β-mercaptoethanol). The mixture was denatured at 95 °C for 5 min and followed by electrophoresis in a 10% polyacrylamide gel. The protein was then transferred to an Immun-Blot™ PVDF Membrane (Bio-Rad) in a TE series transfer electrophoresis unit (Hoefer Inc., Holliston, MA). The membrane was then incubated in blocking buffer (5% nonfat milk powder in TBST) for 1 h followed by incubation with primary antibodies (1:1,000 dilution for nitrotyrosine and IκBα; 1:2,000 dilution for CYP2E1) in TBST (100 mM Tris--HCl, pH 7.5, 0.9% NaCl, and 0.1% Tween 20) overnight at 4 °C with gentle agitation. On the following day, the membrane was washed with TBST and incubated with appropriate secondary antibodies (1:2,000 dilution in TBST) for 2 h at room temperature. Beta actin (Monoclonal; 1:5,000; Sigma, St. Louis, MO) was used as the internal control. After washing off the unbound antibody with TBST, the expression of the antibody-linked protein was determined by an ECL™ Western Blotting Detection Reagents (GE Healthcare). The optical density of the bands was measured and quantified by ImageJ software. The ratio of the optical density of the protein product to the internal control was obtained and was expressed as percentage of the control expression in the Figures.

Enzyme-linked immunosorbent assay measurement {#Sec10}
---------------------------------------------

Enzyme-linked immunosorbent assay (ELISA) measurements of IL-1β, KC, IL-6, and TGF-β~1~ protein expression levels were performed using ELISA development kits from PeproTech (PeproTech Inc., Rocky Hill, NJ). ELISA of COX-2 was conducted using kit purchased from EIAab (Wuhan EIAab Science, Wuhan, China).

Determination of DNA-binding activity of nuclear factor-κB {#Sec11}
----------------------------------------------------------

The assay on the DNA-binding activity of nuclear factor-κB (NF-κB) was performed by electrophoretic mobility shift assay (EMSA) using the Gel Shift Assay Systems from Promega (Promega, Madison, WI). The assay was carried out following the protocol described previously \[[@CR13]\]. Briefly, the phosphorylated and purified consensus NF-κB oligonucleotides (Promega) were mixed with 24 μg of nuclear protein extract and 10× gel shift binding buffer (200 mm Tris--HCl, pH 7.8, 1 m NaCl, 50 mm MgCl~2~, 10 mm EDTA, and 50 mm dithiothreitol). The mixture was incubated at room temperature for 20 min prior to electrophoresis on a 4% non-denaturing polyacrylamide gel. Signals on exposed X-ray films were quantified using laser scanning densitometry. Specificity of NF-κB binding was confirmed by competition assays and the ability of a specific antibody to supershift protein--DNA complexes. In the competition assay, the addition of 100-fold excess of unlabeled competitor consensus oligonucleotide prevented binding. Supershift experiments confirmed the presence of the p50 and p65 subunits in the binding complexes.

Statistical analysis {#Sec12}
--------------------

Data from each group were expressed as means ± SEM. Statistical comparison between groups was made using the Kruskal--Wallis test followed by Dunns post hoc test to compare all groups. A *p* \< 0.05 was considered to be statistically significant (Prism 5.0, Graphpad software, Inc., San Diego, CA, USA).

Results {#Sec13}
=======

CCl~4~ treatment induced hepatocyte necrosis and inflammation surrounding the centrilobular veins of the liver which were obviously attenuated by the pre-treatment of SAMC (Fig. [1](#Fig1){ref-type="fig"}a--d). It should be noted that SAMC injection alone did not show any histological change in the liver (Fig. [1](#Fig1){ref-type="fig"}c). Serum ALT level of CCl~4~-treated mice was approximately 3.5-fold higher than that of the control group. Pre-treatment of SAMC also significantly reduced the expression of serum ALT induced by CCl~4~ to the control-like level. SAMC treatment alone did not change the baseline level of serum ALT (Fig. [1](#Fig1){ref-type="fig"}e; *p* \< 0.05). Previous studies have shown that the isoform 2E1 of cytochrome P450 (CYP2E1) is transiently down-regulated in the early stage of CCl~4~ administration as a self-defense mechanism \[[@CR14]\]. In the present study, protein expression of CYP2E1 was also reduced after CCl~4~ treatment to approximately 50% of that in the control group. Treatment of SAMC alone also led to a significant decrease in CYP2E1 expression which was around 70% of the control level. Levels were further reduced in SAMC and CCl~4~ co-treatment mice when compared with the control group (Fig. [2](#Fig2){ref-type="fig"}a; *p* \< 0.05).Fig. 1Protective effects of SAMC against CCl~4~-induced hepatotoxicity. H&E staining on **a** control, **b** CCl~4~ treatment, **c** SAMC treatment, and **d** CCl~4~ + SAMC groups. CCl~4~ treatment caused obvious centrilobular necrosis in the liver. However, no significant necrosis and inflammation are observed in control, SAMC treatment, and CCl~4~ + SAMC groups. **e** CCl~4~ exposure induced an increase in serum ALT level which was reversed by the pre-treatment of SAMC. Data presented are expressed as Mean ± SEM (*n* = 8--10) and experimental groups marked by *different letters* represented significant differences between groups at *p* \< 0.05 (Kruskal--Wallis test followed by Dunns post hoc test).*Bar* equals 20 micronsFig. 2Antioxidative properties of SAMC. Expression levels of **a** CYP2E1 protein, **b** GPx mRNA, **c** CAT mRNA, and **d** Cu/Zn SOD mRNA were measured in mice liver after CCl~4~ with or without pre-treatment of SAMC. GAPDH and β-actin were used as internal controls for target gene's mRNA and protein expression, respectively. Data presented are expressed as Mean ± SEM (*n* = 8--10) and experimental groups marked by *different letters* represented significant differences between groups at *p* \< 0.05 (Kruskal--Wallis test followed by Dunns post hoc test)

The mRNA levels of antioxidant enzymes GPx, CAT, and Cu/Zn SOD were significantly reduced in CCl~4~ treatment group when compared with the control group. The mice pre-treated with SAMC followed by CCl~4~ injection exhibited similar expression levels of these antioxidant enzymes as the control group (Fig. [2](#Fig2){ref-type="fig"}b--d).

To investigate the effect of SAMC on hepatic lipid peroxidation, levels of hepatic malondialdehyde (MDA) were measured after CCl~4~ with or without SAMC pre-treatment. When compared with the control group, mice treated with CCl~4~ alone showed approximately 3.5-fold increases in the MDA level. However, pre-treatment with SAMC significantly reduced the MDA level (Fig. [3](#Fig3){ref-type="fig"}a). Although SAMC treatment alone also slightly increased the MDA level, the ameliorative effect of SAMC on hepatic lipid peroxidation is obvious.Fig. 3Ameliorative properties of SAMC on lipid peroxidation and NO metabolism. Formation of **a** MDA and **b** nitrotyrosine was measured in mice liver after CCl~4~ with or without pre-treatment of SAMC. β-actin was used as internal control for the formation of nitrotyrosine. Data presented are expressed as Mean ± SEM (*n* = 8--10) and experimental groups marked by *different letters* represented significant differences between groups at *p* \< 0.05 (Kruskal--Wallis test followed by Dunns post hoc test)

As an indicator of cellular oxidative stress and inflammation, the formation of nitrotyrosine was highly elevated (around 1.7-fold than control level) after CCl~4~ treatment. However, when compared with the CCl~4~ group, mice pre-treated with SAMC followed by CCl~4~ showed a significant reduction in nitrotyrosine formation, which was comparable with the control group (Fig. [3](#Fig3){ref-type="fig"}b).

After CCl~4~ treatment, the mRNA expressions of pro-inflammatory factors TNF-α, iNOS, IL-1β, and COX-2 were increased by approximately 3.4, 1.6, 1.7, and 4.1-fold, respectively, when compared with the control group. In the pre-treatment with SAMC followed by CCl~4~ group, the mRNA expression levels of TNF-α, iNOS, and IL-1β were markedly decreased to the basal levels (Fig. [4](#Fig4){ref-type="fig"}a--c). Pre-treatment with SAMC followed by CCl~4~ also markedly reduced the COX-2 mRNA expression when compared with the CCl~4~ group, although to a level not as low as the control group (Fig. [4](#Fig4){ref-type="fig"}e). Protein expression levels of IL-1β and COX-2 confirmed the trends observed in mRNA results (Fig. [4](#Fig4){ref-type="fig"}d, f).Fig. 4Anti-inflammatory properties of SAMC. Expression levels of **a** TNF-α mRNA, **b** iNOS mRNA, **c** IL-1β mRNA, **d** IL-1β protein, **e** COX-2 mRNA, and **f** COX-2 protein were measured in mice liver after CCl~4~ with or without pre-treatment of SAMC. GAPDH was used as internal controls for target gene's mRNA expression. Data presented are expressed as Mean ± SEM (*n* = 8--10) and experimental groups marked by *different letters* represented significant differences between groups at *p* \< 0.05 (Kruskal--Wallis test followed by Dunns post hoc test)

Since the expressions of chemokines in the liver were up-regulated by cytokines, oxidative products, and growth factors during inflammation, the change in expression level and distribution becomes an indicative parameter of hepatic inflammation and oxidation \[[@CR15]\]. After CCl~4~ challenge, mRNA expressions of monocyte chemoattractant protein-1 (MCP-1, CCL2), macrophage inflammatory protein-2 (MIP-2, CXCL3), and murine KC (IL-8 ortholog, CXCL1) increased by 8, 4.5, and 1.7-fold, respectively, when compared with the control group, but significantly reduced in the SAMC and CCl~4~ treatment group (Fig. [5](#Fig5){ref-type="fig"}a--c). ELISA assay of KC protein expression showed similar patterns corresponding to its mRNA expression, further confirming the effect of SAMC on chemokine expressions (Fig. [5](#Fig5){ref-type="fig"}d).Fig. 5Attenuation of chemokine expression by SAMC. Expression levels of **a** MCP-1 mRNA, **b** MIP-2 mRNA, **c** KC mRNA, and **d** KC protein were measured in mice liver after CCl~4~ with or without pre-treatment of SAMC. GAPDH was used as internal controls for target gene's mRNA expression. Data presented are expressed as Mean ± SEM (*n* = 8--10) and experimental groups marked by *different letters* represented significant differences between groups at *p* \< 0.05 (Kruskal--Wallis test followed by Dunns post hoc test)

To investigate the effect of SAMC on hepatic regeneration, we measured the expressions of IL-6 and TGF-β1, which are key genes involved in the processes of regeneration, anti-inflammation, and fibrosis. CCl~4~ challenge significantly up-regulated the expression of these two genes, and the group treated with SAMC and CCl~4~ potentiated such elevated expression (Fig. [6](#Fig6){ref-type="fig"}a, c). Protein expression of IL-6 confirmed the trend of its mRNA expression (Fig. [6](#Fig6){ref-type="fig"}b).Fig. 6Pro-regenerative effect of SAMC. Expression levels of **a** IL-6 mRNA, **b** IL-6 protein, **c** TGF-β~1~ mRNA, and **d** TGF-β~1~ protein were measured in mice liver after CCl~4~ with or without co-treatment of SAMC. GAPDH was used as internal controls for target gene's mRNA expression. Data presented are expressed as Mean ± SEM (*n* = 8--10) and experimental groups marked by *different letters* represented significant differences between groups at *p* \< 0.05 (Kruskal--Wallis test followed by Dunns post hoc test)

Acute CCl~4~ treatment markedly up-regulated the activity level of NF-κB to approximately 2.5-fold of the control. Pre-treatment with SAMC followed by CCl~4~ showed a significant reduction in the activity of NF-κB when compared with the control group. Moreover, cytosolic content of IκBα was significantly decreased by CCl~4~ treatment but restored by the pre-treatment of SAMC (Fig. [7](#Fig7){ref-type="fig"}a). Supershift assay of p50 and p65 antibodies showed a lighter intensity and a slight upward retarded shift of the NF-κB band confirming the specificity of the reactions in the gel shift assay (Fig. [7](#Fig7){ref-type="fig"}b).Fig. 7DNA-binding activity of NF-κB modulated by CCl~4~ and SAMC. **a** Gel shift assay. In CCl~4~-treated group, the activity level of NF-κB (p50 and p65) was significantly increased. Treatment with SAMC markedly reduced the activity level without disturbing the basal activity. In cytoplasm, CCl~4~ treatment stimulated the degradation of IκBα. Pre-treatment of SAMC partially restored the expression of IκBα. **b** Supershift assay conducted with monoclonal p50 and p65 antibodies to test the involvement of these subunits in the gel shift assay. *Arrow* indicates DNA--NF-κB complex. *Arrowhead* indicates shifted DNA--NF-κB band. Data presented are expressed as Mean ± SEM (*n* = 8--10) and experimental groups marked by *different letters* represented significant differences between groups at *p* \< 0.05 (Kruskal--Wallis test followed by Dunns post hoc test)

Discussion {#Sec14}
==========

CCl~4~ was proven to be a useful experimental model for hepatotoxicity studies, although banned for industrial and home use as cleaner and solvent \[[@CR16]\]. A huge number of natural products, mainly originating from traditional Asian medicine, have been tested recently for the protective effects against CCl~4~-induced toxicity such as vitamin E \[[@CR17]\], green tea extracts \[[@CR18]\], ginsan \[[@CR19]\], coffee \[[@CR20]\], and even mushroom \[[@CR21]\]. Because of the similarities in the mechanism of actions, these protective agents also have the potential to be used in the treatment of AFLD (alcoholic fatty liver disease), NAFLD (non-alcoholic fatty liver disease), and cirrhosis \[[@CR22], [@CR23]\]. Sumioka et al. showed that in overdose acetaminophen-induced liver injury model, SAMC protected liver from drug-induced damage by inhibiting CYP2E1 and inducing a biomarker of acetaminophen arylation of liver protein \[[@CR9]\]. In the present study, we demonstrated that administration of SAMC protected CCl~4~-induced acute liver injury through different mechanisms, including the inhibition of CYP2E1, down-regulation of inflammatory mediators and nuclear transcription factor, restoration of intracellular antioxidant enzymes, and promotion of liver regeneration, which added to the novel mechanistic aspects of the known beneficial properties of SAMC.

As an indicative enzyme, ALT is normally contained within liver cells. After cellular damage, the enzyme is released into the bloodstream and raising the blood ALT enzyme level, suggesting the presence of liver damage \[[@CR24]\]. In the present study, CCl~4~ treatment dramatically increased the serum ALT level, induced hepatic centrilobular necrosis, and increased the number of inflammatory cells surrounding the centrilobular veins. We found that pre-treatment with SAMC significantly decreased the serum ALT biomarker as well as ameliorated hepatocellular injury against CCl~4~ without affecting the healthy cells (Fig. [1](#Fig1){ref-type="fig"}).

Through the actions of the cytochrome P450 oxygenase system within the endoplasmic reticulum, mainly the isozyme of CYP2E1, the CCl~3~\* radical is formed by the metabolism of CCl~4~. In the presence of oxygen/hydrogen, CCl~3~\* may convert to CCl~3~OO\*/chloroform to attack many targets including DNA, amino acid, and proteins. CCl~3~OO\* can also abstract a hydrogen to form polyunsaturated fatty acid (PUFA), initiating lipid peroxidation \[[@CR2]\]. In a previous study, it was shown that the expression of CYP2E1 was down-regulated after CCl~4~ intoxication as an adaptive mechanism to limit hepatotoxicity. In addition, restoration of CYP2E1 expression or stabilization of this enzyme made CCl~4~-induced injury more severe \[[@CR14]\]. This finding was further confirmed by a protective assay of ginsan, which is an antioxidant compound from plant, in CCl~4~-induced hepatic injury model \[[@CR19]\]. In this study, SAMC potentiated the down-regulation of CYP2E1 expression induced by CCl~4~. Moreover, SAMC further demonstrated its protective properties by attenuating CCl~4~-induced oxidative stress through the reduction in nitrotyrosine formation and MDA, the end-products of nitric oxide (NO) and lipid peroxidation, respectively (Fig. [3](#Fig3){ref-type="fig"}). In the present study, we further investigated the expression of several hepatic antioxidant enzymes after CCl~4~ challenge. CCl~4~ treatment alone significantly decreased the mRNA expressions of GPx, CAT, and Cu/Zn SOD, whereas pre-treatment with SAMC followed by CCl~4~ had the expressions of those enzymes similar to baseline levels (Fig. [2](#Fig2){ref-type="fig"}). Since Cu/Zn SOD is the main antioxidant which dismutate $\documentclass[12pt]{minimal}
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                \begin{document}$$ {\text{O}}_{2}^{ \cdot - } $$\end{document}$ into H~2~O~2~ and CAT/GPx are enzymes which degrade H~2~O~2~ \[[@CR25]\], these findings are consistent with results seen in the nitrotyrosine and MDA assays, further lending more support to the antioxidative effect of SAMC in mice. Taking all findings together, SAMC protected CCl~4~-induced oxidative stress at different mechanisms.

To further study the mechanism of the protective roles of SAMC, we measured the expressions of inflammatory mediators after CCl~4~ treatment. It has been reported that hepatic inflammatory responses are initiated as early as 30 min after CCl~4~ exposure \[[@CR2]\]. Pro-inflammatory cytokines, TNF-α, and IL-1β are released from Kupffer cells, the resident macrophages in the liver \[[@CR26]\]. When cellular RNA and protein synthesis are repressed by CCl~4~ exposure, hepatocytes becomes sensitized to TNF-α, which induces the activity of transcription factors NF-κB, AP-1, and STAT-3 \[[@CR27]\]. Normally, TNF-α suppresses hepatocellular apoptosis or even to affect recovery through its conjugate receptor TNFR1 and another family member of interleukin, IL-6 \[[@CR28]\]. However, when CCl~4~ inhibits cellular protein synthesis, this cytokine becomes a pro-apoptotic factor which potentiates the apoptotic signaling cascade from ROS-damaged mitochondria \[[@CR29]\]. Similar to TNF-α, when associated with oxidative stress induced by CCl~4~, IL-1β also triggers cellular necrosis and apoptosis pathways by changing the balance of ligand and receptor \[[@CR30], [@CR31]\]. Moreover, elevated expression of TNF-α and IL-1β also stimulates the production of NO, a highly reactive oxidant molecule produced by both parenchymal and non-parenchymal liver cells via iNOS \[[@CR32]\]. In the current study, SAMC greatly reduced the expression levels of pro-inflammatory mediators induced by CCl~4~ exposure at both transcriptional and translational level, confirming its protective role against CCl~4~. Since pre-treatment with SAMC also decreased the protein level of NO metabolic product nitrotyrosine, it could be suggested that the inhibition of pro-inflammatory cytokines and the restoration of antioxidant enzymes during SAMC pre-treatment followed by CCl~4~ intoxication not only prevented cellular necrosis and apoptosis, but also repressed the positive-feedback loop between inflammation, lipid peroxidation, and oxidative stress.

Up-regulation of chemokines in the liver is a part of the inflammation response to haloalkane intoxication, e.g., CCl~4~, via controlling migration and recruitment of both the inflammatory Kupffer cells and the non-inflammatory stellate cells \[[@CR15]\]. Since MCP-1 \[[@CR33]\], MIP-2 \[[@CR34]\], and KC (mouse IL-8 otholog) \[[@CR35]\] are induced by cytokines (e.g., TNF-α) in the inflammatory microenvironment, we tested the effects of SAMC pre-treatment on their expressions after CCl~4~ exposure. Both mRNA and protein levels of these chemokines were significantly down-regulated by the pre-treatment of SAMC followed by CCl~4~, which demonstrated that the anti-inflammation property of SAMC was involved in the regulation of both the inflammatory factors and chemokines.

As an acute phase response factor, IL-6 antagonizes TNFα-induced inflammation and stabilizes cell membranes after CCl~4~ treatment, protecting cells from oxidative stress \[[@CR27]\]. IL-6 also binds to both membrane-bound IL-6 receptor and soluble IL-6 receptor to trigger NF-κB- and STAT3-dependent hepatic regeneration \[[@CR36], [@CR37]\]. TGF-β~1~ is mainly a pro-fibrotic factor in chronic liver disease, e.g., fatty liver disease. However, a recent study also found its role in promoting hepatic remodeling during the process of liver regeneration through increasing the expression of a cell adhesion molecule known as gicerin \[[@CR38]\]. In the present study, SAMC potentiated the induced IL-6 and TGF-β~1~ expressions after CCl~4~ treatment, suggesting the pro-regenerative and the anti-inflammatory properties in SAMC during the early phase of CCl~4~ intoxication. This finding is consistent with other reported studies using different antioxidants \[[@CR19]\].

When an intermediate amount of ROS is generated by CCl~4~ exposure, transcription factors (e.g., NF-κB and AP-1) are activated and translocated into the nucleus. NF-κB and AP-1 then promote the transcription of more inflammatory cytokines and chemokines which form a positive-feedback loop to potentiate the inflammatory response \[[@CR39], [@CR40]\]. Moreover, H~2~O~2~ and NO formed during CCl~4~ intoxication also directly modulate NF-κB activation via an IKK-dependent degradation of IκBα pathway, making this transcription factor a central regulatory molecule in regulating CCl~4~-induced oxidation and inflammation \[[@CR41], [@CR42]\]. In the current study, administration of SAMC prior to CCl~4~ challenge significantly reduced the NF-κB activity through the degradation of cytosolic IκBα. Thus, SAMC may ameliorate both oxidative stress and inflammatory signaling through regulation in the activity of the transcription factor NF-κB.

In conclusion, this study showed that the administration of garlic-derived SAMC was effective in ameliorating CCl~4~-induced hepatotoxicity through the regulation of oxidative stress, inflammatory signaling, and liver regeneration in association with the reduction in the activity of the transcription factor NF-κB. Since AFLD, NAFLD, and other xenobiotics share a similar mechanism in liver damage with the CCl~4~ intoxication model, the hepatoprotective properties of SAMC are of significant clinical application in the prevention and treatment of chronic liver diseases. Compared with other antioxidant agents reported recently, garlic is easier to purchase and in an abundant supply, so it could be used as a daily food supplement which may prevent the onset of liver injury.
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